159 related articles for article (PubMed ID: 9643585)
41. [Establishment of a HepG2 cell line stably expressing human cytochrome P450 1A2 and its metabolic activity].
Zhu-Ge J; Ye S; Yu YN
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 32(5):403-6. PubMed ID: 14610739
[TBL] [Abstract][Full Text] [Related]
42. In vitro anti-mutagenic effect of magnolol against direct and indirect mutagens.
Saito J; Sakai Y; Nagase H
Mutat Res; 2006 Oct; 609(1):68-73. PubMed ID: 16884943
[TBL] [Abstract][Full Text] [Related]
43. Activation of benzo[a]pyrene and 2-aminoanthracene to bacteria mutagens by mussel digestive gland postmitochondrial fraction.
Michel XR; Cassand PM; Narbonne JF
Mutat Res; 1993 Feb; 301(2):113-9. PubMed ID: 7678168
[TBL] [Abstract][Full Text] [Related]
44. Metabolic activation of 10-aza-substituted benzo[a]pyrene by cytochrome P450 1A2 in human liver microsomes.
Yamada K; Suzuki T; Hakura A; Mizutani T; Saeki K
Mutat Res; 2004 Feb; 557(2):159-65. PubMed ID: 14729370
[TBL] [Abstract][Full Text] [Related]
45. Human cytochrome P450 expression in bacteria: Whole-cell high-throughput activity assay for CYP1A2, 2A6 and 3A4.
Esteves F; Campelo D; Urban P; Bozonnet S; Lautier T; Rueff J; Truan G; Kranendonk M
Biochem Pharmacol; 2018 Dec; 158():134-140. PubMed ID: 30308189
[TBL] [Abstract][Full Text] [Related]
46. Development of a high-throughput genotoxicity assay using Umu test strains expressing human cytochrome P450s and NADPH-P450 reductase and bacterial O-acetyltransferase.
Hori H; Hirata D; Fujii W; Oda Y
Environ Mol Mutagen; 2017 May; 58(4):209-216. PubMed ID: 28436560
[TBL] [Abstract][Full Text] [Related]
47. Activation of 3-nitrobenzanthrone and its metabolites by human acetyltransferases, sulfotransferases and cytochrome P450 expressed in Chinese hamster V79 cells.
Arlt VM; Glatt H; Muckel E; Pabel U; Sorg BL; Seidel A; Frank H; Schmeiser HH; Phillips DH
Int J Cancer; 2003 Jul; 105(5):583-92. PubMed ID: 12740904
[TBL] [Abstract][Full Text] [Related]
48. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens.
Crespi CL; Penman BW; Steimel DT; Smith T; Yang CS; Sutter TR
Mutagenesis; 1997 Mar; 12(2):83-9. PubMed ID: 9106248
[TBL] [Abstract][Full Text] [Related]
49. Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
Sadrieh N; Snyderwine EG
Carcinogenesis; 1995 Jul; 16(7):1549-55. PubMed ID: 7614688
[TBL] [Abstract][Full Text] [Related]
50. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
[TBL] [Abstract][Full Text] [Related]
51. Comparative aflatoxin B(1) activation and cytotoxicity in human bronchial cells expressing cytochromes P450 1A2 and 3A4.
Van Vleet TR; Macé K; Coulombe RA
Cancer Res; 2002 Jan; 62(1):105-12. PubMed ID: 11782366
[TBL] [Abstract][Full Text] [Related]
52. Metabolic activation of aflatoxin B1 and 2-amino-3-methylimidazo[4,5-f]-quinoline by human adult and fetal livers.
Kitada M; Taneda M; Ohta K; Nagashima K; Itahashi K; Kamataki T
Cancer Res; 1990 May; 50(9):2641-5. PubMed ID: 2109655
[TBL] [Abstract][Full Text] [Related]
53. CYP1A2 is expressed along with CYP1A1 in the human lung.
Wei C; Cacavale RJ; Kehoe JJ; Thomas PE; Iba MM
Cancer Lett; 2001 Mar; 164(1):25-32. PubMed ID: 11166912
[TBL] [Abstract][Full Text] [Related]
54. Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2.
Turesky RJ; Constable A; Richoz J; Varga N; Markovic J; Martin MV; Guengerich FP
Chem Res Toxicol; 1998 Aug; 11(8):925-36. PubMed ID: 9705755
[TBL] [Abstract][Full Text] [Related]
55. Inter-individual differences in the metabolism of environmental toxicants: cytochrome P450 1A2 as a prototype.
Guengerich FP; Parikh A; Turesky RJ; Josephy PD
Mutat Res; 1999 Jul; 428(1-2):115-24. PubMed ID: 10517985
[TBL] [Abstract][Full Text] [Related]
56. In vitro micronucleus test in HepG2 transformants expressing a series of human cytochrome P450 isoforms with chemicals requiring metabolic activation.
Hashizume T; Yoshitomi S; Asahi S; Matsumura S; Chatani F; Oda H
Mutat Res; 2009; 677(1-2):1-7. PubMed ID: 19501186
[TBL] [Abstract][Full Text] [Related]
57. Selection of human cytochrome P450 1A2 mutants with enhanced catalytic activity for heterocyclic amine N-hydroxylation.
Kim D; Guengerich FP
Biochemistry; 2004 Feb; 43(4):981-8. PubMed ID: 14744142
[TBL] [Abstract][Full Text] [Related]
58. Caffeine potentiates the formation of micronuclei caused by environmental chemical carcinogens in V79 Chinese hamster cells.
Kiefer F; Wiebel FJ
Toxicol Lett; 1998 Aug; 96-97():131-6. PubMed ID: 9820657
[TBL] [Abstract][Full Text] [Related]
59. 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone, forms DNA adducts after metabolic activation by human and rat liver microsomes: evidence for activation by cytochrome P450 1A1 and P450 1A2.
Arlt VM; Hewer A; Sorg BL; Schmeiser HH; Phillips DH; Stiborova M
Chem Res Toxicol; 2004 Aug; 17(8):1092-101. PubMed ID: 15310241
[TBL] [Abstract][Full Text] [Related]
60. Functional characterization of four allelic variants of human cytochrome P450 1A2.
Zhou H; Josephy PD; Kim D; Guengerich FP
Arch Biochem Biophys; 2004 Feb; 422(1):23-30. PubMed ID: 14725854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]